Effects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells

scientific article

Effects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1476-5381.2011.01523.X
P932PMC publication ID3246663
P698PubMed publication ID21649641
P5875ResearchGate publication ID51198998

P50authorAllan D. StruthersQ37841538
P2093author name stringA L Martin
G A Lyles
V Godfrey
P2860cites workNitric oxide and peroxynitrite in health and diseaseQ24645400
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysQ25939005
Drospirenone: pharmacology and pharmacokinetics of a unique progestogenQ28140659
A comparison of the aldosterone-blocking agents eplerenone and spironolactoneQ28276162
The regulation and pharmacology of endothelial nitric oxide synthaseQ28290711
Nitric oxide in septic shockQ33631375
Inducible nitric oxide synthase and cardiovascular disease.Q33869924
Mineralocorticoid selectivity: molecular and cellular aspectsQ33888900
Effect of spironolactone and its metabolites on contractile property of isolated rat aorta ringsQ33913731
Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands.Q34347790
Aldosterone in congestive heart failureQ34472458
Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis inductionQ35100840
The pharmacology of nitric oxide in the peripheral nervous system of blood vesselsQ35139567
iNOS-mediated nitric oxide production and its regulationQ35789162
The new biology of aldosteroneQ36185968
Effects of aldosterone on the vasculatureQ36375830
Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseasesQ36666637
Aldosterone and the vascular systemQ37133549
Glucocorticoid and Mineralocorticoid Cross-Talk with Progesterone Receptor to Induce Focal Adhesion and Growth Inhibition in Breast Cancer CellsQ40616455
RU486 (mifepristone): mechanisms of action and clinical usesQ41360492
Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharideQ41558166
Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cellsQ42472118
Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cellsQ43709273
Amlodipine inhibits pro-inflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon-gamma-stimulated cultured vascular smooth muscle cellsQ44065929
Aldosterone Inhibits Inducible Nitric Oxide Synthase in Neonatal Rat CardiomyocytesQ44405066
Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritisQ44585210
Direct and indirect effects of aldosterone on cyclooxygenase-2 and interleukin-6 expression in rat cardiac cells in culture and after myocardial infarction.Q44814504
The evolution of aldosterone antagonistsQ44889504
Expression of inducible nitric oxide synthase in cultured smooth muscle cells from rat mesenteric lymphatic vesselsQ45061549
Regulation of the expression of inducible nitric oxide synthaseQ45089049
Inter-strain differences in glucocorticoid and mineralocorticoid effects on macrophage and lymphocyte functions in miceQ46350892
Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II.Q46689526
Glucocorticoid-related signaling effects in vascular smooth muscle cellsQ46696400
Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells.Q53856893
Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells.Q54637233
Guide to Receptors and Channels (GRAC), 4th EditionQ56639335
Physical separation of aortic corticoid receptors with type I and type II specificitiesQ70090706
Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 betaQ70936080
Progesterone inhibits arterial smooth muscle cell proliferationQ73677598
17Beta-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cellsQ77370926
Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cellsQ77370970
Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptorQ79273396
P4510describes a project that usesImageJQ1659584
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectaortaQ101004
P304page(s)2003-2014
P577publication date2011-12-01
P1433published inBritish Journal of PharmacologyQ919631
P1476titleEffects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells
P478volume164

Reverse relations

cites work (P2860)
Q101578601Role of mineralocorticoid receptor antagonists in kidney diseases
Q54350807Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB.

Search more.